Fake coronavirus vaccines an ‘emerging threat’ to UK ,

New Post Public Reply Private Reply Replies (0) Message Board
Crunch55
356
Fake coronavirus vaccines an ‘emerging threat’ to UK , crime agency boss warns
A National Crime Agency boss says he 'absolutely expects' criminals to start offering fake coronavirus vaccines when the real ones start rolling out to UK citizens

SHARE
BY JEZ HEMMING
14:34, 14 NOV 2020
1_Coronavirus-Covid-19-Vaccine.jpg
The National Crime agency is warning against fake vaccines as release of genuine on draws near(Image: Getty Images)
Sign up to FREE email alerts from Daily Star - Daily News
Enter email
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains more about how we use your data, and your rights. You can unsubscribe at any time.
A National Crime Agency boss says he "absolutely expects" heartless criminals to try selling fake Covid vaccines when real ones roll out.

Fraudsters have already peddled fake PPE and Covid-19 test kits during the pandemic as people increasingly buy products online.



Reports of fraud relating to online shopping, investments and romance have also increased during the pandemic, said NCA National Economic Crime Centre director general Graeme Biggar.

Speaking to a webinar held by the Resilience First Group he said people have attempted to scam Government furlough schemes and business relief, writes the Independent.


The warning came after the National Cyber Security Centre (NCSC) said cyberattacks by Russia and other hostile states present an "ongoing threat" to UK efforts to develop a vaccine.


Even fake testing kits have been sold by heartless scammers(Image: Getty Images/iStockphoto)
RELATED ARTICLES
Anti-vaxxers 'could be banned from going into work if they don't get Covid jab'
Record coronavirus spike due to drinkers heading to pub before lockdown, experts claim
Mr Biggar said criminals were using Covid as "hook" to try different types of fraud. He added: "The new emerging threat will be around vaccine fraud.

"We haven’t seen much of that yet but we absolutely expect when vaccines begin to roll out that there will be people offering fake vaccines. We are trying to get ahead of that trend now."

Paul Chichester, the NCSC’s director of operations, said hostile states were focused on vaccine research, while criminal groups were also targeting hospitals and healthcare bodies.


Drug giant Pfizer believes its Covid vaccine could be approved next month(Image: REUTERS)
READ MORE
Donald Trump's grey hair baffles internet as he almost concedes to Joe Biden
"It’s an ongoing threat and it continues to date," he said earlier this month. "We know states are interested in a variety of elements of the vaccine work – the research behind it is part of that but also knowledge around the success, the trial data.

"It’s also about the likelihood of the supply chain being successful, and a variety of different elements of the vaccine as we move from doing the research to the delivery and supply of it. States are trying to understand how the UK is prepared for that."

Drug giant Pfizer announced this week it believes its vaccine is 90% effective against the Covid-19 virus.

The government has said that if approved, delivery of the vaccine from Belgium would not be affected by any delays caused by Brexit from 1 January.

Two UK vaccine trials are also ongoing - one developed by US biotechnology company Novavax and one by the University of Oxford.

MORE ON
Donald TrumpBrexitCrimeRussiaCoronavirusFraud
NEWS
SPORT
SHOWBIZ
TV
TECH
LIFE & STYLE
TRAVEL
PICS
FOLLOW US
© 2020 a Reach plc subsidiary

Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 29

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 28

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 24

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 35

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 30

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 20

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Endava Investors: Legal Action Could Recover Your Losses

Updated Category News Views 87

Endava got tangled in a class action lawsuit over securities fraud back in 2024. Investors were already feeling the squeeze as whispers about declining demand for its services echoed through the trading floor. You know how it goes—when rumors hit, shares take a dive faster than you can blink. Class Action Reality: Who Gets to Play? The lawsuit targeted shareholders who...

Continue Reading
New Mortgage Ratings Assigned to Deephaven Trust Portfolio

Updated Category News Views 177

Introduction to Deephaven Residential Mortgage Trust 2024-1 In an important development within the non-prime mortgage market, KBRA has recently assigned preliminary ratings to eight classes of mortgage-backed notes from Deephaven Residential Mortgage Trust 2024-1 (DRMT 2024-1). This $514.6 million transaction comprises a unique pool of 1,330 residential mortgages,...

Continue Reading
Meta Platforms Declares Cash Dividend for Shareholders

Updated Category News Views 325

Quarterly Cash Dividend Announcement from Meta Platforms The board of directors of Meta Platforms, Inc. (NASDAQ: META) has recently declared a quarterly cash dividend of $0.525 per share, benefitting shareholders holding both Class A and Class B common stock. This dividend reflects the company's ongoing commitment to returning value to its shareholders. Dividend Payment...

Continue Reading
Campine Expects Strong Financial Upsurge in 2024 Performance

Updated Category News Views 125

Campine NV Forecasts Impressive Growth in 2024 Campine NV, a well-known name in the metals recycling and specialty chemicals sector, is gearing up for a promising financial year ahead. The company has recently indicated that it anticipates higher profits in 2024, thanks to favorable market conditions. Projected Revenue Growth for 2024 According to Campine's expectations,...

Continue Reading
Thumzup Media's Strategic Investment in Dogecoin Ahead of ETFs

Updated Category News Views 147

Thumzup Media's Strategic Move into Dogecoin Thumzup Media Corporation (Nasdaq: TZUP) has made headlines with its latest purchase of Dogecoin, securing around 7.5 million tokens valued at approximately $2 million. This significant acquisition marks the company's first open-market investment in Dogecoin, reflecting a strong belief in the digital currency's potential for...

Continue Reading